The first imitation of the application for production of six kinds of generic drug of HISCO
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the website of the State Food and Drug Administration (CFDA) on June 18, six generic drugs of HISCO, fondagangui sodium injection, were applied for production and joined in the first simulation queue Fondagangui sodium injection is suitable for major orthopedic patients to prevent the occurrence of venous thromboembolism The target of the product is clear, mainly through the combination with antithrombin (ATIII), accelerating thrombin (at) inactivating factor Xa, which is an indirect XA factor inhibitor with strong XA factor inhibition The product was officially approved by the FDA in December 2001 and officially launched in China in 2008 The product is called "Arixtra" At present, although there is no manufacturer in China, Hengrui pharmaceutical and Huadong pharmaceutical, which have strong strength, are all in the line of the first imitation.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
